Paul Perreault, CSL Behring CEO
CSL CEO Paul Perreault determined to grow plasma collection after full-year sales dip
As the ink dries on CSL’s $11.7 billion Vifor buyout, the company posted a dip in profits, due in part to a drop in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
